Two-Year Follow-Up after Contact Force Sensing Radiofrequency Catheter and Second-Generation Cryoballoon Ablation for Paroxysmal Atrial Fibrillation: A Comparative Single Centre Study

Table 1

Patients’ baseline characteristics (LA: left atrial, NOACs: novel oral anticoagulants).

Patients (n)	RG group (58)	CB group (40)	p value
Age (years)	61 ± 9	59 ± 10	ns
Female gender n (%)	20 (34)	13 (32.5)	ns
LA size (mm)	42.1 ± 4.6	41.3 ± 4	ns
Hypertension (%)	30 (51%)	17 (42.5)	ns
Type II diabetes (%)	3 (5.1)	2 (5)	ns
Coronary artery disease (%)	7 (12)	5 (12.5)	ns
Medication prior to ablation
Beta blockers (%)	55 (95)	40 (100)	ns
Propafenone (%)	24 (41)	12 (30)	ns
Sotalol (%)	2 (3)	0 (0)	ns
Amiodarone (%)	2 (3)	1 (2.5)	ns
Acenocoumarol (%)	40 (69)	29 (72.5)	ns
NOACs (%)	5 (8.6)	4 (10)	ns